Comments
Loading...
Immunocore Hldgs (IMCR) Forecast
NewsEarningsImmunocore Hldgs (IMCR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmunocore Hldgs (NASDAQ:IMCR) Stock Quotes, Forecast and News Summary
Immunocore Hldgs Stock (NASDAQ: IMCR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunocore Hldgs (IMCR) stock?
You can purchase shares of Immunocore Hldgs (NASDAQ:IMCR) through any online brokerage.
Who are Immunocore Hldgs (IMCR) competitors?
Other companies in Immunocore Hldgs’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the forecast, or price target, for Immunocore Hldgs (IMCR) stock?
Immunocore Hldgs has a consensus price target of $71.00.
What is the current price for Immunocore Hldgs (IMCR)?
The stock price for Immunocore Hldgs (NASDAQ: IMCR) is $28.2 last updated December 24, 2024 at 11:58 AM EST.
Does Immunocore Hldgs (IMCR) pay a dividend?
There are no upcoming dividends for Immunocore Hldgs.
When is Immunocore Hldgs (NASDAQ:IMCR) reporting earnings?
Immunocore Hldgs’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Immunocore Hldgs (IMCR) going to split?
There is no upcoming split for Immunocore Hldgs.
What sector and industry does Immunocore Hldgs (IMCR) operate in?
Immunocore Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.